Loading...
Clonal hematopoiesis and measurable residual disease assessment in acute myeloid leukemia
Current objectives regarding treatment of acute myeloid leukemia (AML) include achieving complete remission (CR) by clinicopathological criteria followed by interrogation for the presence of minimal/measurable residual disease (MRD) by molecular genetic and/or flow cytometric techniques. Although ad...
Saved in:
| Published in: | Blood |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Society of Hematology
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7225688/ https://ncbi.nlm.nih.gov/pubmed/32232484 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019004770 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|